Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients

Background: Although useful in the time-race against COVID-19, CPAP cannot provide oxygen over the physiological limits imposed by severe pulmonary impairments. In previous studies, we reported that the administration of the SLAB51 probiotics reduced risk of developing respiratory failure in severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinchieri, Vito, Marazzato, Massimiliano, Ceccarelli, Giancarlo, Lombardi, Francesca, Piccirilli, Alessandra, Santinelli, Letizia, Maddaloni, Luca, Vassalini, Paolo, Mastroianni, Claudio Maria, d’Ettorre, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405060/
https://www.ncbi.nlm.nih.gov/pubmed/36009399
http://dx.doi.org/10.3390/biomedicines10081851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405060/
https://www.ncbi.nlm.nih.gov/pubmed/36009399
http://dx.doi.org/10.3390/biomedicines10081851

Ejemplares similares